Tag: Clinical Trials

Median combined enrollment of minority race/ethnicity groups was below corresponding population demographics based on census estimates

Black patients disproportionately excluded from participation in pancreatic cancer clinical trials

No improvement seen in representation of Black patients after implementation of a 2015 FDA action plan to improve diversity

50-mg dose shows significant improvement versus placebo for sleep onset, sleep maintenance, and total sleep time

29 percent of patients deemed appropriate for intervention were Hispanic compared with 52 percent of those deemed not appropriate

Outcomes better for Black men compared with White men in clinical trials of definitive radiotherapy for localized prostate cancer

Most support pediatric research posing minimal risk and research posing greater risk if it has high social value

The use of FE_NO testing in addition to usual care is suggested for patients with asthma in whom treatment is being considered

Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health

84.7 percent of patients in clinical trials were White and 54.8 percent were men; underrepresentation seen in trials of nearly all phases